A novel SCARB2 mutation in progressive myoclonus epilepsy indicated by reduced β-glucocerebrosidase activity
- 1 April 2014
- journal article
- case report
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 339 (1-2) , 210-213
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- A case of severe hearing loss in action myoclonus renal failure syndrome resulting from mutation in SCARB2Movement Disorders, 2012
- Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2mutations in isolated AMRF featuresBMC Neurology, 2011
- Mutation of SCARB2 in a Patient With Progressive Myoclonus Epilepsy and Demyelinating Peripheral NeuropathyArchives of Neurology, 2011
- Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand β-glucocerebrosidaseHuman Molecular Genetics, 2009
- SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failureAnnals of Neurology, 2009
- A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndromeHuman Molecular Genetics, 2008
- Array-Based Gene Discovery with Three Unrelated Subjects Shows SCARB2/LIMP-2 Deficiency Causes Myoclonus Epilepsy and GlomerulosclerosisThe American Journal of Human Genetics, 2008
- LIMP-2 Is a Receptor for Lysosomal Mannose-6-Phosphate-Independent Targeting of β-GlucocerebrosidaseCell, 2007
- Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorderBrain, 2004
- Myoclonic Epilepsy in Gaucher Disease: Genotype-Phenotype Insights from a Rare Patient SubgroupPediatric Research, 2003